ID	Database	Citation
23856005	Pubmed	"11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer? Storbeck KH, Bloem LM, Africander D, Schloms L, Swart P, Swart AC. Mol Cell Endocrinol. 2013 Sep 5;377(1–2):135–46.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23856005"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23856005"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23856005"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
32629108	Pubmed	"The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1. Barnard L, Nikolaou N, Louw C, Schiffer L, Gibson H, Gilligan LC, et al. J Steroid Biochem Mol Biol. 2020 Sep;202:105724.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/32629108"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/32629108"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/32629108"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
